aXivite® is a branded ingredient developed by aXichem AB and based on phenylcapsaicin, a proprietary capsaicin analogue. It is designed for use in selected dietary supplement and functional ingredient formulations. Its microencapsulation technology is intended to help control pungency and support handling during formulation. <Cite refs={["turn179113search3","turn179113search20"]}/>
Phenylcapsaicin is a proprietary compound developed by aXichem. It is chemically related to capsaicin, the pungent compound found in chilli peppers, but has a distinct molecular structure.
aXivite® is the branded ingredient form marketed for dietary supplement applications. The product information describes a microencapsulated formulation intended to make the active ingredient easier to handle and to provide controlled release characteristics. The exact composition and concentration must be confirmed for the commercial grade being supplied. <Cite refs={["turn179113search3","turn179113search21"]}/>
Microencapsulation can help manage the handling and release characteristics of an ingredient. For aXivite®, the brand owner describes this technology as a way to control pungency and support ingredient incorporation into finished formulations.
Phenylcapsaicin is the active compound associated with aXivite®. The brand's product materials distinguish the active compound from the microencapsulated ingredient formulation. Confirm whether the offered material is the branded formulation, its declared active concentration, and the applicable assay method before entering numerical values in the product catalogue.
The ingredient is marketed for selected dietary supplement applications, including sports nutrition, weight-management formulations, and formulations investigating ingredient bioenhancement. Suitability depends on the formulation, intended use, evidence supporting the proposed claims, and applicable regulations. <Cite refs={["turn179113search3","turn179113search5"]}/>
aXivite® is marketed for selected sports nutrition formulations. Any statements about exercise performance, fatigue, or recovery should be limited to claims supported by suitable evidence and permitted in the target market.
The ingredient is marketed for weight-management supplement development. Do not describe it as a treatment for obesity or promise weight loss without appropriate evidence and regulatory authorisation.
The branded ingredient is also positioned for selected gut-health formulations. Product descriptions should distinguish research findings from established clinical outcomes and avoid disease-treatment claims.
aXivite® product materials discuss its use in research involving the uptake of other ingredients, including curcumin. Any claim that it increases the bioavailability of a particular compound should be supported by relevant evidence for the specific formulation and use. <Cite refs={["turn179113search5","turn179113search6"]}/>
Because aXivite® is a branded ingredient, buyers should verify the product's authenticity and authorised supply chain. Request the current technical data sheet, certificate of analysis, active-compound concentration, microencapsulation composition, assay method, storage conditions, and batch-specific quality results.
Additional documentation may include contaminant testing, stability data, safety information, and regulatory documentation for the destination market. Do not substitute specifications for generic capsaicin or another phenylcapsaicin preparation.
Regulatory status depends on the product category, intended use, market, and current authorisation conditions. The brand owner reports authorisation for specified dietary supplement or food uses in the European Union and the United States. These authorisations should not be interpreted as blanket approval for every formulation, claim, or country. Verify the applicable current requirements before commercialisation. <Cite refs={["turn179113search1","turn179113search2"]}/>
Contact Mediocon Inc. to enquire about availability, authorised sourcing, product concentration, packaging, and technical documentation, subject to current supply arrangements. Confirm the precise branded grade and its permitted application before purchasing.
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying aXivite® Microencapsulated Phenylcapsaicin Manufacturer in India | Mediocon Inc. and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our aXivite® Microencapsulated Phenylcapsaicin Manufacturer in India | Mediocon Inc. is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance